Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice.
about
Innovative drugs to treat depression: did animal models fail to be predictive or did clinical trials fail to detect effects?Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.Dental noise exposed mice display depressive-like phenotypes.Chronic mild stress (CMS) in mice: of anhedonia, 'anomalous anxiolysis' and activityCurrent investigational drugs for major depressionBipolar disorder: candidate drug targets.Increased anxiety in corticotropin-releasing factor type 2 receptor-null mice requires recent acute stress exposure and is associated with dysregulated serotonergic activity in limbic brain areas.Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal modelsProgress in corticotropin-releasing factor-1 antagonist development.Social features of scent-donor mice modulate scent marking of C57BL/6J recipient males.Failure to mount adaptive responses to stress results in dysregulation and cell death in the midbrain rapheCorticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.The protective role of Bax inhibitor-1 against chronic mild stress through the inhibition of monoamine oxidase AAssociation between repeated unpredictable chronic mild stress (UCMS) procedures with a high fat diet: a model of fluoxetine resistance in miceOpen questions in current models of antidepressant action.Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signalingIn search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice.Corticotropin-releasing factor 1 receptor-mediated mechanisms inhibit colonic hypersensitivity in rats.Chaihu-Shugan-San administration ameliorates perimenopausal anxiety and depression in ratsEffect of the fragrance inhalation of essential oil from Asarum heterotropoides on depression-like behaviors in mice.Emerging experimental therapeutics for bipolar disorder: clues from the molecular pathophysiology.Mechanisms of action of antidepressants: from neurotransmitter systems to signaling pathways.Chronic mild stress and antidepressant treatment alter 5-HT1A receptor expression by modifying DNA methylation of a conserved Sp4 siteInnovative approaches for the development of antidepressant drugs: current and future strategiesEffects of chronic mild stress in female bax inhibitor-1-gene knockout mice.Hippocampal PPARδ Overexpression or Activation Represses Stress-Induced Depressive Behaviors and Enhances Neurogenesis[(76) Br]BMK-152, a nonpeptide analogue, with high affinity and low nonspecific binding for the corticotropin-releasing factor type 1 receptor.Cellular adaptations of dorsal raphe serotonin neurons associated with the development of active coping in response to social stress.Corticolimbic transcriptome changes are state-dependent and region-specific in a rodent model of depression and of antidepressant reversalThe Antidepressant Effect of Angelica sinensis Extracts on Chronic Unpredictable Mild Stress-Induced Depression Is Mediated via the Upregulation of the BDNF Signaling Pathway in RatsPioglitazone, a PPARγ agonist rescues depression associated with obesity using chronic unpredictable mild stress model in experimental mice.Curcumin Alters Neural Plasticity and Viability of Intact Hippocampal Circuits and Attenuates Behavioral Despair and COX-2 Expression in Chronically Stressed RatsThe chronic mild stress (CMS) model of depression: History, evaluation and usageNeuropharmacological evaluation of a novel 5-HT3 receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice.The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments.Corticotropin-releasing hormone, glutamate, and γ-aminobutyric acid in depression.Sex differences in corticotropin-releasing factor receptor-1 action within the dorsal raphe nucleus in stress responsivity.Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety.Innovations in CNS drug discovery: differentiating strategies to treat depression.Towards translational rodent models of depression.
P2860
Q26996411-BAC42B75-043E-4748-8402-668061DBF3D2Q27014879-B27395BD-2150-4595-8358-E96BADF36613Q27300794-D59026E1-C92F-4BC3-9F1E-8D3CF6B8640BQ27438109-58DD21B1-0BE2-46F5-9775-E23DCF8CF132Q28244223-EBAE61E5-0338-4237-BFFE-6982BDD0366AQ28751133-29A507A7-C020-47E8-893E-345A67007FA4Q30438084-E3C33757-A81A-4562-904E-847BEBD2FE56Q30466695-3DA63D2E-2880-4D7A-B0E0-BBA62762D078Q30475627-14C4D358-ADB0-40B8-93C0-C3743382AF7BQ30478177-5A1E23F1-1888-4C83-B36D-CEA31A5A35FAQ30483717-13C8C450-0DE9-440B-8671-968AEFCAEE82Q30502566-47681C89-8119-470B-B27D-A924401EF41DQ30558195-F48FFA24-4E9C-4665-9435-BF3F10BAD5EDQ33570573-A9E5B1C9-EA47-4A87-AAA2-EB12D9367534Q33767182-A7B0CD0C-46D9-4D68-ADB5-8CD7272EE763Q34203214-3D55B52C-93DF-48D0-962C-DBC3EE20F399Q34292427-A9490E0B-C576-44A7-8FB5-EFDDA3D8E035Q34421388-E852BE3C-0F92-41F4-B5A1-B11F548C0C05Q34981498-B181B7EB-F6F2-4AC4-BF7D-944D43A589C9Q35162554-EFA28F0E-F8D0-4BC3-A295-AA8D857F34A9Q35770190-0A217DE5-1670-4C38-98A4-6F12747E6EB8Q36026076-6F4E9534-55A4-4F59-A499-CF1A126C1CA6Q36268893-6DD6A09E-4D4F-4B6E-9B74-72CC7217884FQ36401400-13EF4418-E732-4DB8-9C9C-0852F4299497Q36600857-9B12B213-D404-4BA4-BB4D-F907FE95BCB0Q36634037-8B6B1C77-3388-4F29-8017-2C5DC063B409Q36764636-80D45934-9591-4DCA-B488-9AC6868B7B2BQ36828404-57F2794A-705E-4B86-9212-5AEA026249A4Q37159953-B4E989AE-11AA-4BC3-89CA-22EDF7FDAFFFQ37239649-8AE21487-20CA-4F6B-B2C0-A479B8D70E44Q37486869-9A39FD16-9F9F-4583-8CFE-9E6F82D85038Q37607374-8A4E91FE-7A70-4667-BED6-F55E74C36620Q37648894-C4B81133-900B-4C0C-BFBE-A4AC66929F92Q37703556-39C0AEAC-E733-4140-8249-72FCA045789EQ37709437-475C9408-F19F-41B9-A689-8072B57AC7ECQ37710849-8BB4B417-C42A-4AA3-8DB9-525BE3869EAEQ37720094-183867B3-FD41-4BB6-B745-8127AAFE76DEQ37794546-04870590-8334-4DEA-9D50-CC083069616CQ38088733-42B86475-6D4E-4C84-942F-47279002D718Q38092709-33BE9BA9-79FC-440B-8253-5B6C61592447
P2860
Effects of the selective nonpeptide corticotropin-releasing factor receptor 1 antagonist antalarmin in the chronic mild stress model of depression in mice.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Effects of the selective nonpe ...... s model of depression in mice.
@ast
Effects of the selective nonpe ...... s model of depression in mice.
@en
Effects of the selective nonpe ...... s model of depression in mice.
@nl
type
label
Effects of the selective nonpe ...... s model of depression in mice.
@ast
Effects of the selective nonpe ...... s model of depression in mice.
@en
Effects of the selective nonpe ...... s model of depression in mice.
@nl
prefLabel
Effects of the selective nonpe ...... s model of depression in mice.
@ast
Effects of the selective nonpe ...... s model of depression in mice.
@en
Effects of the selective nonpe ...... s model of depression in mice.
@nl
P1476
Effects of the selective nonpe ...... s model of depression in mice.
@en
P2093
Cecile Ducottet
P304
P356
10.1016/S0278-5846(03)00051-4
P577
2003-06-01T00:00:00Z